Crystal structure of 2-(5-(pyridin-3-yl)-4-(pyridin-4-yl)-4H-1,2,4-triazol-3-yl)pyridine, C17H12N6
C17H12N6, monoclinic, P21/n (no. 14), a = 5.8617(14) Å, b = 15.845(4) Å, c = 15.326(4) Å, β = 92.650(5)°, V = 1422.0(6) Å3, Z = 4, Rgt(F) = 0.0449, wRref(F2) = 0.1132, T = 296(2) K.
Main Authors: | Sun Hongtao, Wu Hao, Zhang Lili |
---|---|
Format: | Article |
Language: | English |
Published: |
De Gruyter
2020-08-01
|
Series: | Zeitschrift für Kristallographie - New Crystal Structures |
Subjects: | |
Online Access: | https://doi.org/10.1515/ncrs-2020-0223 |
Similar Items
-
2-(5-{6-[5-(Pyrazin-2-yl)-1H-1,2,4-triazol-3-yl]pyridin-2-yl}-1H-1,2,4-triazol-3-yl)pyrazine
by: Zhouqing Xu, et al.
Published: (2011-09-01) -
3-Pyridin-2-yl-1H-1,2,4-triazol-5-amine
by: Anton V. Dolzhenko, et al.
Published: (2009-01-01) -
2,6-Bis(4H-1,2,4-triazol-4-yl)pyridine dihydrate
by: De-quan Jiao, et al.
Published: (2011-11-01) -
2,6-Bis(4H-1,2,4-triazol-4-yl)pyridine dihydrate
by: Shang Yuan Liu, et al.
Published: (2011-07-01) -
2-{[5-(Pyridin-4-yl)-4-p-tolyl-4H-1,2,4-triazol-3-yl]methyl}acrylic acid hemihydrate
by: Renata Paprocka, et al.
Published: (2014-01-01)